News
India’s most expensive cinematic production—a mega-budget retelling of the beloved Hindu epic Ramayana—has divided film critics and cultural purists even as it draws packed crowds across theatres. While audiences have celebrated its ambitious visual scale and star-studded lineup, the film faces sharp pushback over colloquial language, creative departures from classical texts, and an over-reliance on visual effects at the expense of emotional depth.
The Bombay High Court has ordered the Election Commission to restore six members of a Goa family whose names were deleted from the voter rolls during a recent revision drive. Justices Valmiki Menezes and Amit Jamsandekar gave officials 10 days to fix the list and criticized an unfair bureaucratic trap where computer rejections forced regular voters into filing forms meant only for first-time electors.
The Democratic Party’s decisive victory in capturing both chambers of the US Congress marks a watershed moment of institutional recalibration against Trumpism. With President Donald Trump framing the midterms as a personal referendum, voters across historically red strongholds—including Texas, Kansas, and the Carolinas—delivered an unmistakable rebuke, restoring constitutional checks and balances and demonstrating democracy’s resilience against extreme polarization.
The latest chapter of Indian football’s fiercest rivalry ended in a dramatic 1-1 tie, leaving the ISL title race completely unresolved. After Edmund Lalrindika put East Bengal ahead late in the game, Jason Cummings struck a 90th-minute equalizer to keep both teams level at the top of the table.
15th may | India The Supreme Court on Thursday expressed concern over the Centre’s 2023…
15th May | Dalal Street Dalal Street shook off a shaky start on Thursday to…
15th May | India On May 14, 2026, the Election Commission of India (ECI) officially…
The sudden passing of 38-year-old Prateek Yadav due to a massive blood clot has shocked Uttar Pradesh. Despite his focus on fitness and business, medical complications following a recent surgery led to a fatal heart and lung failure, bringing together political rivals in a moment of shared grief.
In a milestone for neurological care, Eli Lilly has officially introduced Lormalzi (donanemab) to the Indian market as of May 2026. As the first “disease-modifying” therapy available domestically, the drug marks a departure from symptom management by actively removing amyloid plaques from the brain. Priced at ₹91,688 per vial, the intravenous infusion is administered every four weeks and can potentially be stopped once plaque clearance is achieved. With India’s dementia cases projected to more than double by 2036, the CDSCO-approved treatment, supported by a specialized “alternative access program,” represents a critical shift toward active medical intervention for the country’s aging population.
Advertisement
